Search results for Zanolimumab ELISA Kit
Zanolimumab ELISA Kit, ProteoGenix, KPTX138
Description of Zanolimumab ELISA Kit The Structure of Zanolimumab ELISA Kit Zanolimumab ELISA Kit is a highly sensitive and specific enzyme-linked immunosorbent assay (ELISA) kit designed for the quantitative detection of zanolimumab in biological samples. The kit is composed of several components including a microplate coated with a monoclonal antibody specific for zanolimumab, a zanolimumab standard, and a detection antibody labeled with an enzyme. The microplate is made of high-quality polystyrene and is divided into 96 wells, each of which is coated with the monoclonal antibody. This antibody is designed to specifically bind to zanolimumab, ensuring the accuracy and specificity of the assay. The zanolimumab standard is a known concentration of the therapeutic antibody, which is used to generate a standard curve for the quantification of zanolimumab in the sample. The detection antibody is labeled with an enzyme, which allows for the visualization and quantification of zanolimumab in the sample. The enzyme used in the kit is horseradish peroxidase (HRP), which catalyzes a colorimetric reaction upon the addition of a substrate. This reaction produces a color change that is directly proportional to the amount of zanolimumab present in the sample. The Activity of Zanolimumab ELISA Kit Zanolimumab ELISA Kit is a highly sensitive and specific assay that utilizes the principle of sandwich ELISA. This technique involves the capture of zanolimumab by the monoclonal antibody coated on the microplate, followed by the detection of zanolimumab using the labeled detection antibody. The colorimetric reaction produced by the enzyme allows for the quantification of zanolimumab in the sample. The kit has a high sensitivity, with a lower limit of detection of 0.1 ng/mL. This means that even low concentrations of zanolimumab can be accurately detected and quantified. The assay also has a wide dynamic range of 0.2-100 ng/mL, allowing for the detection of both low and high levels of zanolimumab in the sample. The activity of the kit is not affected by the presence of other therapeutic antibodies or proteins in the sample, ensuring the accuracy and specificity of the results. The assay also has a high reproducibility, with a coefficient of variation (CV) of less than 10%. The Application of Zanolimumab ELISA Kit Zanolimumab ELISA Kit has a wide range of applications in the field of therapeutic antibody research and development. It can be used for the quantitative detection of zanolimumab in various biological samples, including serum, plasma, and cell culture supernatants. One of the main applications of the kit is in the pharmacokinetic (PK) and pharmacodynamic (PD) studies of zanolimumab. The accurate quantification of zanolimumab levels in the sample can provide valuable information on the absorption, distribution, metabolism, and excretion of the therapeutic antibody. It can also help in determining the optimal dosage and dosing frequency of zanolimumab for maximum efficacy. Zanolimumab ELISA Kit can also be used for the screening and characterization of zanolimumab in hybridoma cell lines and in the purification process of zanolimumab. It can aid in the development and optimization of production processes, ensuring the quality and consistency of zanolimumab. In addition, the kit can also be used in clinical trials to monitor zanolimumab levels in patients receiving treatment. This can help in evaluating the efficacy of the therapeutic antibody and in determining the appropriate treatment regimen for individual patients. In conclusion, Zanolimumab ELISA Kit is a highly sensitive and specific assay that is essential for the accurate quantification of zanolimumab in various biological samples. Its wide range of applications makes it a valuable tool in therapeutic antibody research and development, aiding in the development of effective treatments for various diseases.
Host
Reactivity
Applications
Conjugation
Zanolimumab ELISA Kit, Abbexa, abx395027
Zanolimumab ELISA Kit is a quantitative ELISA kit for detection of Zanolimumab.Zanolimumab is a biosimilar that targets CD4. The CD4 antigen is involved in the recognition of MHC class II molecules and is a co-receptor for HIV. CD4 is primarily expressed in a subset of T-lymphocytes, also referred to as T helper cells, but may also be expressed by other cells in the immune system, such as monocytes, macrophages, and dendritic cells. At the tissue level, CD4 expression may be detected in thymus, lymph nodes, tonsils, and spleen, and also in specific regions of the brain, gut, and other non-lymphoid tissues. CD4 functions to initiate or augment the early phase of T-cell activation through its association with the T-cell receptor complex and protein tyrosine kinase, Lck. It may also function as an important mediator of direct neuronal damage in infectious and immune-mediated diseases of the central nervous system. Multiple alternatively spliced transcripts have been identified in this gene [RefSeq, July 2017].
Host
Reactivity
Human
Applications
ELISA
Conjugation
Please provide the required information below so that we can quickly source your products.